Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(4 sites)

Italy

Istituto di Ricovero e Cura Carattere Scientifico San Raffaele, Milan, Milan

Spain

University Hospital of Santiago de Compostela, Santiago de Compostela, A Coruna

Hospital Universitario de Navarra, Pamplona, Navarre

Sweden

Karolinska Institutet, Stockholm, Stockholm County